We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » MSD and Genentech Settle PTO Dispute Over Cabilly Patent
MSD and Genentech Settle PTO Dispute Over Cabilly Patent
Merck Sharp & Dohme Corp. is settling its challenge over a Genentech patent on methods for artificially synthesizing antibodies, a process used for a variety of specialty medicines and cancer therapies.